ProfileGDS4718 / 214528_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 12% 15% 22% 13% 15% 13% 23% 9% 16% 14% 8% 19% 14% 16% 13% 12% 18% 11% 6% 17% 18% 7% 11% 19% 18% 9% 13% 7% 15% 15% 14% 19% 11% 13% 8% 17% 22% 22% 15% 10% 13% 13% 17% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9583815
GSM549102patient 115, normal, homogenized [OPG study]3.8476112
GSM549104patient 119, normal, homogenized [OPG study]3.9403215
GSM549108patient 138, normal, homogenized [OPG study]4.2418522
GSM549119patient 077, normal, homogenized [OPG study]3.8885713
GSM549133patient 032, cancer, homogenized [OPG study]3.9061415
GSM549139patient 042, cancer, homogenized [OPG study]3.8727113
GSM549099patient 107, normal, homogenized [OPG study]4.2831323
GSM549109patient 139, normal, homogenized [OPG study]3.786599
GSM549110patient 046, normal, homogenized [OPG study]3.9832616
GSM549114patient 063, normal, homogenized [OPG study]3.9150214
GSM549122patient 082, normal, homogenized [OPG study]3.730158
GSM549134patient 033, cancer, homogenized [OPG study]4.1077819
GSM549136patient 036, cancer, homogenized [OPG study]3.8910414
GSM549140patient 044, cancer, homogenized [OPG study]3.9811316
GSM549111patient 047, normal, homogenized [OPG study]3.8875813
GSM549113patient 057, normal, homogenized [OPG study]3.8169512
GSM549132patient 031, cancer, homogenized [OPG study]4.0668618
GSM549137patient 038, cancer, homogenized [OPG study]3.8121411
GSM549142patient 047, cancer, homogenized [OPG study]3.656756
GSM549100patient 110, normal, homogenized [OPG study]4.0420817
GSM549107patient 135, normal, homogenized [OPG study]4.0296518
GSM549115patient 068, normal, homogenized [OPG study]3.646887
GSM549116patient 072, normal, homogenized [OPG study]3.8083611
GSM549120patient 078, normal, homogenized [OPG study]4.0930319
GSM549131patient 030, cancer, homogenized [OPG study]4.0087218
GSM549118patient 074, normal, homogenized [OPG study]3.73429
GSM549129patient 027, cancer, homogenized [OPG study]3.8975513
GSM549123patient 088, normal, homogenized [OPG study]3.697847
GSM549124patient 006, cancer, homogenized [OPG study]4.0047915
GSM549126patient 015, cancer, homogenized [OPG study]3.933115
GSM549128patient 025, cancer, homogenized [OPG study]3.8875814
GSM549103patient 117, normal, homogenized [OPG study]4.1605919
GSM549117patient 073, normal, homogenized [OPG study]3.8208811
GSM549138patient 041, cancer, homogenized [OPG study]3.8892613
GSM549141patient 045, cancer, homogenized [OPG study]3.651468
GSM549130patient 028, cancer, homogenized [OPG study]4.0625317
GSM549101patient 111, normal, homogenized [OPG study]4.224122
GSM549105patient 128, normal, homogenized [OPG study]4.2275722
GSM549106patient 134, normal, homogenized [OPG study]3.9016415
GSM549112patient 048, normal, homogenized [OPG study]3.7822110
GSM549125patient 011, cancer, homogenized [OPG study]3.8901713
GSM549127patient 024, cancer, homogenized [OPG study]3.8736313
GSM549135patient 035, cancer, homogenized [OPG study]3.9951917